Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Morgan Stanley

Amazon Key To Rivian's Strategy, EV Maker's Cash Burn In Question, Says Morgan Stanley Analyst

Rivian Automotive Inc’s (NASDAQ: RIVN) highly ambitious and capital intensive plan to ramp up production after initially missing production and delivery target last year could invite investor scrutiny on Wednesday when the electric vehicle startup reports first-quarter earnings after the bell, accordi

Benzinga

IBM Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on IBM (NYSE:IBM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Visa Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Visa (NYSE:V). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Morgan Stanley Maintains Overweight Rating for Global E Online: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Global E Online (NASDAQ:GLBE) and lower its price target from $70.00 to $48.00. Shares of Global E Online are trading down 8.99% over the last 24 hours, at $18.01 per share.

Benzinga

Morgan Stanley Maintains Overweight Rating for Warner Music Group: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Warner Music Group (NASDAQ:WMG) and lower its price target from $50.00 to $40.00. Shares of Warner Music Group are trading down 4.05% over the last 24 hours, at $27.96 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022

Upgrades

Benzinga

10 Biggest Price Target Changes For Monday

Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Morning Brief: Top Financial Stories Dominating on Monday, May 9

CNBC Ford Motor Selling 8M Shares Of Rivian Automotive

Benzinga

Elon Musk’s takeover financing deal could clip Twitter’s wings

The Tesla tycoon’s complex bid for the social media platform will load the tech firm with debt

The Guardian - UK

Florida pension fund sues Elon Musk and Twitter to stop buyout

The class-action lawsuit argues that the deal cannot close before 2025

The Guardian - US

Looking At Morgan Stanley's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Morgan Stanley (NYSE:MS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Wells Fargo, M&T Cited in Bullish Bank of America Bank-Stock Report

The 'potential for a less dire macro outlook exists on the back of easing inflationary pressures,' Bank of America says, touting bank stocks.

The Street

Check Out What Whales Are Doing With Visa

A whale with a lot of money to spend has taken a noticeably bearish stance on Visa. Looking at options history for Visa (NYSE:V) we detected 11 strange trades.

Benzinga

Looking At Moderna's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

'Still A Second-Half Story': Twilio Analysts React To Mixed Q1 Earnings

Twilio Inc (NYSE: TWLO) shares dropped 2.7% on Thursday after the company reported conservative second-quarter guidance.

Benzinga

Check Out What Whales Are Doing With BMY

Someone with a lot of money to spend has taken a bullish stance on Bristol-Myers Squibb (NYSE:BMY). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Check Out What Whales Are Doing With MRNA

Businessweek

Wall Street Isn’t Ready for the Crackdown Coming Its Way

Federal investigations into questionable trading practices are on the rise—and the fate of Bill Hwang and his firm, Archegos, may await others in the finance industry.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Caesars Entertainment Whale Trades For May 04

Someone with a lot of money to spend has taken a bearish stance on Caesars Entertainment (NASDAQ:CZR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Catalent (NYSE:CTLT) and lower its price target from $145.00 to $132.00. Shares of Catalent are trading up 1.11% over the last 24 hours, at $101.06 per share. A move to $132.00 would account for a 30.62% increase from the current…

Benzinga

4 Starbucks Analysts On Q2 Earnings: Brewing China Concerns, Strong US Demand And More

Starbucks shares were rallying Wednesday after the coffee chain reported a second-quarter sales beat. The quarter was helped by strong growth and momentum in the North American segment. The big headwind facing the company is the impact of the China region, which analysts highlighted after the print.

Benzinga

MGM Resorts Analysts React To Q1 Earnings Beat, LeoVegas Acquisition, Macau Weakness

MGM Resorts International (NYSE: MGM) shares traded lower by 3.5% on Tuesday after the company reported first-quarter earnings and revenue beats but a quarterly drop in Las Vegas Strip occupancy.

Benzinga

Here's Why Morgan Stanley Remained Bullish On Nvidia

Morgan Stanley analyst Joseph Moore reinstated NVIDIA Corp (NASDAQ:NVDA) with an Equal-Weight and a $217 price target. The price target implies an upside of 11.9%. Moore observes that Nvidia has "differentiated" offerings in the cloud and artificial intelligence and a leading position in gaming. Moore also highlighted concerns about a slowdown in gaming and its…

Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Chegg: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Chegg (NYSE:CHGG) and lower its price target from $37.00 to $20.00. Shares of Chegg are trading down 29.92% over the last 24 hours, at $17.50 per share. A move to $20.00 would account for a 14.25% increase from the current…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

1 … 45 46 47 48

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations